期刊文献+

鲍曼不动杆菌肺炎37例临床分析 被引量:7

The clinical analysis of the pneumonia caused by aeinetobacter baumannii
原文传递
导出
摘要 目的探讨医院内感染不动杆菌肺炎的临床特点、危险因素及抗生素的敏感性。方法回顾性分析37例鲍曼不动杆菌肺炎患者的临床表现、痰细菌培养及药物敏感试验结果。结果37例不动杆菌肺炎多发生在[CU病房、多数有侵袭性治疗、机械通气患者;亚胺培南、丁胺卡那霉素、哌拉西林/他唑巴坦是较为有效药物,对其他抗菌药物耐药率均较高;死亡5例,泛耐药菌株患者病死率41.7%,明显高于非泛耐药菌株患者(死亡2例,病死率8%)。结论鲍曼不动杆菌是医院重要的多重耐药致病菌,宜根据药敏试验结果选用有效抗生素,对有危险因素者应及时行细菌培养加药敏试验。 Objective To observe the clinical characteristics, risk factors, and sensitivity to antibiotics of nosocomial infections caused by acinetobaeter baumannii. Methods Data were retrospectively collected from all isolated 37 strains acinetobacter. The clinical features, results of suptum culture and test of drug sensitivity were reviewed. Results The 37 acinetobacter baumannii strains mainly distributed in intensive care unit (ICU), most of them had the risk factors of receiving invasive treatment, mechanical ventilation, ect. The antibiotics imipenem, amikacin,pipercillin/tazobactam showed good efficacy for patients with acinetobacter infection,but other antibiotics had highly drug resistant rate. 5 were dead. The mortality of nosocomial infections caused by multi-drug resistant acinetobacter was 41.7 % ,which was much higher than the non-multi-drug resistant's(2 dead, the mortality was 8 % ). Conclusion Acinetobacter is one of the most important multi-drug resistant pathogen in nosocomial infec- tions. Antimicrobial agents should be chosen according to antimicrobial susceptibility test results. Patients who have the risk factors of nosocomial infections caused by acinetobacter should have suptum culture and antibiotic susceptibility studies as soon as possible.
出处 《中国基层医药》 CAS 2008年第5期773-774,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 鲍氏不动杆菌 肺炎 抗药性 细菌 Acinetobaeter baumannii Pneumonia Drug resistance,bacterial
  • 相关文献

参考文献3

二级参考文献25

  • 1张冰,滕春燕,张曙东.下呼吸道感染不动杆菌的药敏分析[J].中国实验诊断学,2005,9(1):84-85. 被引量:1
  • 2王辉,孙宏莉,廖康,陈冬梅,王清涛,王飞燕,陈民钧,朱元珏.北京和广州地区四家医院不动杆菌碳青霉烯酶基因型研究[J].中华检验医学杂志,2005,28(6):636-641. 被引量:121
  • 3中华医学会呼吸病学会.医院内获得性支气管-肺感染诊断标准[J].中华结核和呼吸杂志,1990,13:372-372.
  • 4Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, Pa.
  • 5Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbial,1995, 33 : 2233-2239.
  • 6Levesque C, Piche L, Larose C, et al. PCR mapping of integrons reveals several novel combination of resistance genes. Antimicrob Agents Chemother, 1995, 39 : 185-191.
  • 7Jeon BC, Jeong H, Bae K, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing OXA-23 β-lactamase in Korea. J Clin Microb, 2005, 43:2241-2245.
  • 8Dalla-Costa LM, Coelho JM, Souza HAPHM, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microb, 2003, 41:3403-3406.
  • 9Villers D, Espase E, Coste-Burel M, et al. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann Intern Med, 1998, 129: 182-189.
  • 10Manikal VM, Landman D, Saurina G, et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York.- citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis, 2000, 31 : 101-106.

共引文献194

同被引文献64

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部